Cellbox Solutions

Next-gen portable CO₂ incubators for secure #livecellshipping — enabling #celltherapy, #organoids, #iPSCs & more.
#stemcells #tissueengineering #organonachip

[Cellbox Solutions @Cellbox_]

Not too much. Not too little. Just the right conditions.
🧫 Advanced cell models tend to appreciate that.

Across Sweden and Denmark, Nordic Biolabs AB supports researchers with Cellbox™ portable CO₂ incubators featuring active CO₂ and temperature control for the transport of live cell cultures and cell-based material.

Your local contact for Cellbox™ solutions in the Nordics. 😊

#CellTransport #Cellbox #LifeSciences #CellTherapy

[Cellbox Solutions @Cellbox_]

🔔 #ArticleoftheMonth The same signal. Different outcome. In a recent study, Özkan et al. found that forces resembling normal intestinal movement amplified inflammation and fibrosis in an inflammatory bowel disease-on-a-chip model.

An interesting example of how biological context can shape cellular responses.

➡️https://t.co/4P7xqZupWO

#organonachip #advancedmodels #nams

[Cellbox Solutions @Cellbox_]

Transporting live cells under perfect laboratory conditions just became even more seamless for the regulatory pathway. The technical data (DMF) for the technology of all our Cellbox™ has been filed with the FDA, meaning our full portfolio is now ready for clinical studies.

What this means for our Cell & Gene Therapy partners:
⚡ Accelerated Approvals: Seamlessly cross-reference our file in your submissions.
📉 Zero Friction: Eliminate redundant paperwork and speed up your clinical trial timelines.

#CellboxSolutions #WarmChainLogistics #FDACompliance #CellTherapy #ClinicalTrials #Biotech

[Cellbox Solutions @Cellbox_]

🧬 Clinical Trials Day highlights how fast Cell & Gene Therapy is evolving.

But as therapies scale across sites and borders, another challenge becomes increasingly important: infrastructure.

How do we move living materials without compromising functionality along the way?

▶️ At Meeting on the Med in Rome, our CFO/CBO Dr. Bernd Mühlenweg spoke with Onyx about warm chain transport, controlled live cell logistics, and the future scalability of advanced therapies.

We recently explored these challenges further here:
https://t.co/vyWdMQYiXc

#cellandgenetherapy #clinicaltrialsday #advancedtherapies

[Cellbox Solutions @Cellbox_]

#articleoftheweek Cells do not function in isolation. Their environment matters.

A new Nature Biomedical Engineering study mapped how human bone marrow mesenchymal stromal cells are positioned within their native niche and how this changes with age.

A reminder that biological quality is shaped long before any readout begins.

If cellular context matters inside the body, should it matter more across the workflow?

🔗 https://t.co/rgRgkEXMGI

#stemcells #regenerativemedicine

[Cellbox Solutions @Cellbox_]

This becomes critical in space-related research using organoids.

[Cellbox Solutions @Cellbox_]

Not everything that changes in microgravity is caused by microgravity.

(parabolic flight experiment, Beghin & Greni Lab, Mechanobiology Institute, NUS)

[Cellbox Solutions @Cellbox_]

Cells don’t “pause” during transport.
Their state before the experiment already shapes the outcome.

#organoids #spaceresearch

[Cellbox Solutions @Cellbox_]

Advances in healthcare rely on reliable biology.
But variability does not start in the lab.

Handling, packaging, and transport already influence cellular behavior and downstream results.

Reproducibility begins before the experiment.

#cellculture #biotech #worldhealthday #cellbox

[Cellbox Solutions @Cellbox_]

Not every lab delivery arrives by standard courier.
But safe transport for living cells always matters.
Happy Easter from Cellbox Solutions.🐇

Learn more about live cell transport here:
https://t.co/1IhB9TOyMz

#celltransport #biotech #cellbox

[Cellbox Solutions @Cellbox_]

We’ve closed the first tranche of our Series A financing round, raising ~€3.5M led by @Companisto together with existing investors, including https://t.co/edEIisvYQj.

The funding will accelerate the global expansion of our warm-chain logistics platform for transporting living cells and new applications in life sciences.

We’re also excited to welcome Dr. Bernd Muehlenweg as Chief Business Officer & Chief Financial Officer.

Read the full press release here: https://t.co/3gU6VJe0X2

[Cellbox Solutions @Cellbox_]

When environmental control and usability come together, cell logistics becomes more predictable and scalable across facilities.
#celltransport #reproducibility

[Cellbox Solutions @Cellbox_]

🧫 Modern cell transport requires more than environmental control. Practical usability and seamless workflow integration are becoming essential for predictable and scalable research operations across sites.

#celltransport #reproducibility #lifescience

[Cellbox Solutions @Cellbox_]

New year. New beginnings.
Wishing everyone celebrating a joyful Lunar New Year ✨
#LunarNewYear

[Cellbox Solutions @Cellbox_]

As cell therapies scale globally, manufacturing and logistics are becoming biologically relevant variables rather than purely operational ones. This work, developed together with Fraunhofer, highlights how transport conditions can shape downstream cell therapy performance. Worth a closer look. Link: https://t.co/2IiYhsnwpU

[Cellbox Solutions @Cellbox_]

NK cell therapies are moving closer to routine clinical use, but logistics remain an underestimated variable. Comparative data suggest cryopreservation can reduce viability and functional cytotoxicity compared to controlled live transport conditions, highlighting how handling can directly influence therapeutic cell quality.

[Cellbox Solutions @Cellbox_]

A concise and worthwhile read for researchers working in stem cells, organoids, and translational immunology.
➡️ https://t.co/gwwYGgzUSL

[Cellbox Solutions @Cellbox_]

#ArticleoftheWeek
A recent study in Nature Communications by Tsutsui et al. introduces a 3D organoid-based artificial thymus to improve generation of functional iPSC-derived immune cells. Another strong contribution from Kyoto’s iPSC ecosystem.

Thread 👇

[Cellbox Solutions @Cellbox_]

This could strengthen future cell-based immunotherapies and improve reliability of iPSC-derived immune cell manufacturing.